Sutro Biopharma STRO
NASDAQ STRO
$16.10 +0.07 (+0.44%)
At close: Sep 29, 2026 · 4:00 PM EDT

Sutro Biopharma (STRO) Capital Expenditures (2017 - 2025)

Updated

Sutro Biopharma (STRO) recorded Capital Expenditures of $184,000 in Q4 2025, down 82.8% from $1.07 million a year earlier and down 26.7% from the prior quarter.

Analysis

Sutro Biopharma (STRO) Capital Expenditures (2017 - 2025) Analysis & Trends

For FY2025, Sutro Biopharma reported Capital Expenditures of $1.7 million, down 45.3% from FY2024.

  • Annual Capital Expenditures has declined for four straight years, with a five-year compound annual growth rate of -25.0% (FY2020 to FY2025).
  • Across earlier years, Capital Expenditures came in at $3.1 million in FY2024 (-28.2%), $4.32 million in FY2023 (-45.1%), $7.86 million in FY2022 (-48.7%) and $15.32 million in FY2021 (+114.9%).
  • Quarterly Capital Expenditures has ranged from $86,000 in Q2 2025 to $5.41 million in Q2 2021 over the past five years.
  • On a year-over-year basis, Capital Expenditures has declined for three consecutive quarters, with an average decline of 7.1% over the last eight quarters.
  • Peak year-over-year performance for Capital Expenditures in the last five years was growth of 211.4% in Q1 2021, against a decline of 88.6% in Q2 2025 at the low end.
  • Per Business Quant, the preceding three quarters came in at $251,000 (Q3 2025), $86,000 (Q2 2025) and $1.17 million (Q1 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 1.32 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 322.00 Mn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 893.00 Mn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -321.00 Mn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -763.00 Mn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 513.00 Mn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 140.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 533.00 Mn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 112.20 Mn
10 Sutro Biopharma 265.72 Mn -412.78 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 184,000.00
Sep 30, 2025 251,000.00
Jun 30, 2025 86,000.00
Mar 31, 2025 1.17 Mn
Dec 31, 2024 1.07 Mn
Sep 30, 2024 828,000.00
Jun 30, 2024 756,000.00
Mar 31, 2024 446,000.00
Dec 31, 2023 1.44 Mn
Sep 30, 2023 328,000.00
Jun 30, 2023 1.60 Mn
Mar 31, 2023 942,000.00
Dec 31, 2022 3.37 Mn
Sep 30, 2022 738,000.00
Jun 30, 2022 2.20 Mn
Mar 31, 2022 1.55 Mn
Dec 31, 2021 2.54 Mn
Sep 30, 2021 5.00 Mn
Jun 30, 2021 5.41 Mn
Mar 31, 2021 2.38 Mn
API Access

Sutro Biopharma Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=STRO&period=max&api_key=YOUR_API_KEY